摘要:
A screening method and an identification method for a compound which prevents cells from the infection with hepatitis C virus (HCV) comprising measuring the affinity with a fibroblast growth factor receptor (FGFR) or the ability to block the binding to HCV and thus selecting or judging a test compound.